Avana Health

Avana Health is a clinical-stage biotechnology and medtech company dedicated to transforming women's healthcare through innovative uterine-focused treatments. Founded in 2021 and based in Lexington, Kentucky, the company is developing a proprietary platform designed to provide safe, effective, and same-day procedural solutions for maternal health crises, specifically abnormal uterine bleeding (AUB) and postpartum hemorrhage (PPH). Their development pipeline includes the HemmoStat system for PPH management and AHC-01, a therapeutic candidate for AUB currently in clinical evaluation. By focusing on accessibility and ease of use within existing gynecologic workflows, Avana Health aims to significantly reduce maternal mortality and address the global unmet needs of over one billion women.